Jeff Kasher

Jeff Kasher is a board member at Javara. Jeff was previously the executive director of the autoimmune platform team at Eli Lilly and Company. Jeff has also held positions at Patients Can't Wait, LLC and Catalyst Clinical Research, LLC.

Kasher has been instrumental in establishing and actively managing a portfolio of innovative clinical development approaches to achieve 50% cost and time reductions over a five year period. Jeff has also built strategic partnerships across the industry to leverage new ideas & technologies, accelerate clinical development beyond iterative improvement, and mitigate significant risk. In addition, Kasher has advocated for and implemented patient centric approaches to clinical research, including: study design, matching patients to appropriate trials, and engaging patient groups, sites, and ‘the crowd’ (lillycoi.com).

Jeff Kasher received their B.S. in Chemistry from Franklin & Marshall College, then went on to obtain their Doctor of Philosophy (Ph.D.) in Pharmacology from State University of New York Upstate Medical University. Afterward, they became a Post Doctoral Fellow at Yale University School of Medicine.